Michelle Lupton
Has grant
Team Head
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics
Open Date: 2021-09-05
Close Date: 2023-08-31
Grant: Close
Blood testing to predict and discriminate dementias
Open Date: 2021-06-11
Close Date: 2026-05-31
Grant: Close
Methylation-based biomarkers for prodromal Alzheimer’s disease
Open Date: 2021-01-01
Close Date: 2022-01-01
Grant: Close
Genetic Investigations for Prodromal Alzheimerâ s disease
Open Date: 2018-01-01
Close Date: 2021-12-31
Grant: Close
Women’s Academic Fund. Carer Funding
Open Date: 2017-01-01
Close Date: 2017-01-01
Articles (7)
Year:
2026
Year:
2026
Year:
2026
Biomarkers from diverse methodological domains are increasingly important in the detection, diagnosis and tracking of neurological diseases and brain health, yet they are often evaluated in isolation. Statistical integration approaches, such as factor analysis, provide a means to combine complementary biomarkers and capture higher-order domains of brain health. Exploratory factor analysis has previously been employed to identify latent brain health constructs using multimodal MRI, fluid biomarkers and cardiovascular risk factors in a non-clinical older population. The current study aimed to validate this integrative framework using confirmatory factor analysis in an independent cohort and test construct associations with cognition and diagnosis of mild cognitive impairment (MCI) or Alzheimer’s disease (AD) dementia. Data were analysed from 197 participants in the Prospective Imaging Study of Ageing, including 157 cognitively normal controls (CN), 18 participants with MCI and 22 participants with early AD dementia. MRI, cardiovascular, and plasma biomarker processing closely replicated previous methods. Confirmatory factor analysis was conducted in CNs to validate the previously reported latent constructs. Weighted factor composites were then compared between each diagnostic group and tested for associations with cognitive performance (verbal reasoning, verbal memory, visual memory and language) and sensitivity to MCI and AD diagnosis. Three factors were reproducible across cohorts: 1) Brain & Vascular Health (hippocampal and ventricular volumes, cerebral blood flow); 2) White Matter (WM) Fluid Dysregulation (Free Water, WM enlarged perivascular spaces); and 3) Blood Biomarkers (GFAP, NfL, pTau181). Compared to the CN group, both MCI (β=−1.25, SE=0.19, p <.001) and AD dementia (β=−1.52, SE=0.16, p <.001) participants had lower Brain & Vascular Health composite scores. MCI (β=0.80, SE=0.20, p <.001) and AD dementia (β=1.85, SE=0.17, p <.001) participants also had higher Blood Biomarkers composite scores than CNs, but there was no difference in WM Fluid Dysregulation scores across groups (F (2,192) = 0.89, p =.411). The Brain & Vascular Health composite had the strongest association with MCI/AD dementia among all individual measures and composites. Across all participants, Brain & Vascular Health and Blood Biomarkers composite scores were associated with tests of cognition ( p <.0125), while WM Fluid Dysregulation did not show any significant associations. These findings demonstrate that reproducible, multimodal composites can index distinct yet complementary dimensions of brain health relevant to cognition and AD dementia. Importantly, this work highlights the value of an adaptable, integrative framework for combining imaging and plasma biomarkers to characterise system-level brain health and support early detection and mechanistic investigation of cognitive decline and neurodegenerative disease.
Year:
2026
Year:
2025
Background Alzheimer’s dementia (AD) is a leading cause of disability and dependency in older adults. Frailty is a phenotypic risk factor for AD, but its causal role remains unclear - partly due to reliance on composite scores that may obscure distinct mechanisms. Methods We applied a Mendelian randomisation (MR) framework using two large GWAS of clinically diagnosed AD. Frailty exposures were derived from a multivariate genomic SEM model comprising one general factor and six domain-specific domains. Bidirectional univariable MR (UVMR) estimated total effects on AD, while multivariable MR (MVMR) adjusted for educational attainment, household income, and longevity. Results The general frailty factor showed no evidence of a causal effect on AD. The unhealthy lifestyle frailty domain increased AD risk in UVMR (OR = 6.60, 95% CI: 2.36-18.50, q = 0.021 and OR = 3.12, 95% CI: 1.57-6.19, q = 0.001), but these effects attenuated substantially in MVMR, with betas reduced by ∼66-94% and ORs falling to ∼1.1-1.5 (non-significant), consistent with overlap with socioeconomic pathways. The disability frailty domain was nominally protective in UVMR, but positively associated with AD in MVMR (OR = 1.69, 95% CI: 1.21-2.36, q = 0.007). The poorer cognition frailty domain increased AD risk in MVMR when adjusted for education and income (OR = 1.55, 95% CI: 1.12-2.15, q = 0.025), though this effect attenuated by ∼37% with further adjustment for longevity. Sensitivity analyses indicated that this cognition-AD signal was partly driven by SNPs in SPI1, a well-established AD risk locus, consistent with pleiotropic overlap rather than an independent domain. No reverse effects were observed. Conclusions Frailty comprises genetically distinct domains with differential causal relevance for AD. These findings highlight disability-related frailty as a potential causal contributor to AD, whereas cognitive frailty is likely predominantly driven by shared aetiology, -underscoring the need to move beyond composite frailty indices when evaluating dementia risk.
Year:
2025
Frailty is a multifaceted clinical state associated with accelerated aging and adverse health outcomes. Informed etiological models of frailty hold promise for producing widespread health improvements across the aging population. Frailty is currently measured using aggregate scores, which obscure etiological pathways that are only relevant to subcomponents of frailty. Therefore, we performed the first multivariate genome-wide association study of the latent genetic architecture between 30 frailty deficits, which identified 408 genomic risk loci. Our model included a general factor of genetic overlap across all deficits, plus six novel factors indexing shared genetic signal across specific groups of deficits. Follow-up analyses demonstrated the added clinical and etiological value of the six factors, including predicting frailty in external datasets, divergent genetic correlations with clinically relevant outcomes, and unique underlying biology linked to aging. This suggests nuanced models of frailty are key to understanding its causes and how it relates to worse health.
Year:
2024
Collaborators (27)
Jurgen Fripp
Biomedical Informatics Group Leader
CSIRO
Nicholas Ashton
Assistant Professor
Banner Alzheimer’s Institute
Henrik Zetterberg
Professor
University of Gothenburg
Ian H. Harding
Group Leader
QIMR Berghofer Medical Research Institute
Tom C. Russ
Reader in Old Age Psychiatry
University of Edinburgh
Isabelle Francesca Foote
Lecturer in Genomics and Ageing
Queen Mary University of London
Tobias Karakach
Assistant Professor
Dalhousie University
Alan Marshall
Senior Lecturer in Quantitative Methods
University of Edinburgh
Donncha Mullin
Honorary Clinical Lecturer
University of Edinburgh
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Matthew Pase
Associate Professor
MONASH UNIVERSITY
Andrew Grotzinger
Associate Professor
Memorial University of Newfoundland
Brittany Mitchell
Senior Research Fellow
QIMR Berghofer Medical Research Institute
David D. Ward
University of Queensland
Kenneth Rockwood
Professor
Nova Scotia Health Authority
Janice Ranson
Senior Research Fellow
University of Exeter
Anna Elisabeth Fürtjes
Research Associate in Statistical Genetics
University of Edinburgh
David Whiteman
Deputy Director
QIMR Berghofer Medical Research Institute
Meng Law
Professor and Director of Radiology
MONASH UNIVERSITY
Andrew D. Rutenberg
Dalhousie University
Enda Byrne
Senior Research Fellow
University of Queensland
Nicholas Martin
Senior Scientist and Senior Principal Research Fellow
QIMR Berghofer Medical Research Institute
Anna Behler
Newcastle University
Catherine Olsen
QIMR Berghofer Medical Research Institute
Michael Breakspear
Professor
Newcastle University
Gail A. Robinson
University of Queensland
Michelle Luciano
University of Edinburgh
Make your next move.
Prepare your application
Review drafts before you send them.